Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Dexa-BEAM in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
NCT02099292Phase 2Completed
- Start
- May 2001
- Primary completion
- May 2005
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of rituximab in B-cell non-Hodgkin lymphoma. Started May 2001; status: completed.
02
Drugs
rituximab
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT02099292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099292.